VaQDENV

Italy
|
2024-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • Arbovirus
  • Dengue virus
  • Vector-borne disease
  • Arboviral disease
  • Vector-borne disease
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • Qdenga